Literature DB >> 14687607

Guanine derivatives modulate L-glutamate uptake into rat brain synaptic vesicles.

Carla I Tasca1, Tiago G Santos, Rejane G Tavares, Ana M O Battastini, João B T Rocha, Diogo O Souza.   

Abstract

Glutamate uptake into synaptic vesicles is driven by a proton electrochemical gradient generated by a vacuolar H(+)-ATPase and stimulated by physiological concentrations of chloride. This uptake plays an important role in glutamatergic transmission. We show here that vesicular glutamate uptake is selectively inhibited by guanine derivatives, in a time- and concentration-dependent manner. Guanosine, GMP, GDP, guanosine-5'-O-2-thiodiphosphate, GTP, or 5'-guanylylimidodiphosphate (GppNHp) inhibited glutamate uptake in 1.5 and 3 min incubations, however, when incubating for 10 min, only GTP or GppNHp displayed such inhibition. By increasing ATP concentrations, the inhibitory effect of GTP was no longer observed, but GppNHp still inhibited glutamate uptake. In the absence of ATP, vesicular ATPase can hydrolyze GTP in order to drive glutamate uptake. However, 5mM GppNHp inhibited ATP hydrolysis by synaptic vesicle preparations. GTP or GppNHp decreased the proton electrochemical gradient, whereas the other guanine derivatives did not. Glutamate saturation curves were assayed in order to evaluate the specificity of inhibition of the vesicular glutamate carrier by the guanine derivatives. The maximum velocity of the initial rate of glutamate uptake was decreased by all guanine derivatives. These results indicate that, although GppNHp can inhibit ATPase activity, guanine derivatives are more likely to be acting through interaction with vesicular glutamate carrier.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14687607     DOI: 10.1016/j.neuint.2003.08.001

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  9 in total

1.  Intranasal guanosine administration presents a wide therapeutic time window to reduce brain damage induced by permanent ischemia in rats.

Authors:  Denise Barbosa Ramos; Gabriel Cardozo Muller; Guilherme Botter Maio Rocha; Gustavo Hirata Dellavia; Roberto Farina Almeida; Leticia Ferreira Pettenuzzo; Samanta Oliveira Loureiro; Gisele Hansel; Ângelo Cássio Magalhães Horn; Diogo Onofre Souza; Marcelo Ganzella
Journal:  Purinergic Signal       Date:  2015-12-23       Impact factor: 3.765

2.  Neuroprotection Promoted by Guanosine Depends on Glutamine Synthetase and Glutamate Transporters Activity in Hippocampal Slices Subjected to Oxygen/Glucose Deprivation.

Authors:  Tharine Dal-Cim; Wagner C Martins; Daniel T Thomaz; Victor Coelho; Gabriela Godoy Poluceno; Débora Lanznaster; Samuel Vandresen-Filho; Carla I Tasca
Journal:  Neurotox Res       Date:  2016-02-08       Impact factor: 3.911

3.  The neuroprotective effect of propofol against brain ischemia mediated by the glutamatergic signaling pathway in rats.

Authors:  Jinsong Cai; Yuyan Hu; Wenbin Li; Li Li; Shuqin Li; Min Zhang; Qingjun Li
Journal:  Neurochem Res       Date:  2011-05-10       Impact factor: 3.996

4.  Intracerebroventricular guanine-based purines protect against seizures induced by quinolinic acid in mice.

Authors:  André P Schmidt; Thiago T Avila; Diogo O Souza
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

5.  Cannabinoid-glutamate interactions in the regulation of food intake in neonatal layer- type chicks: role of glutamate NMDA and AMPA receptors.

Authors:  Negar Keyshams; Morteza Zendehdel; Vahab Babapour; Ali Baghbanzadeh
Journal:  Vet Res Commun       Date:  2016-03-22       Impact factor: 2.459

6.  Unfolding New Roles for Guanine-Based Purines and Their Metabolizing Enzymes in Cancer and Aging Disorders.

Authors:  P Di Iorio; S Beggiato; M Ronci; C B Nedel; C I Tasca; M Zuccarini
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

Review 7.  The Guanine-Based Purinergic System: The Tale of An Orphan Neuromodulation.

Authors:  Valentina Di Liberto; Giuseppa Mudò; Roberta Garozzo; Monica Frinchi; Víctor Fernandez-Dueñas; Patrizia Di Iorio; Renata Ciccarelli; Francesco Caciagli; Daniele F Condorelli; Francisco Ciruela; Natale Belluardo
Journal:  Front Pharmacol       Date:  2016-06-17       Impact factor: 5.810

Review 8.  Guanosine: a Neuromodulator with Therapeutic Potential in Brain Disorders.

Authors:  Débora Lanznaster; Tharine Dal-Cim; Tetsadê C B Piermartiri; Carla I Tasca
Journal:  Aging Dis       Date:  2016-10-01       Impact factor: 6.745

Review 9.  Neuromodulatory Effects of Guanine-Based Purines in Health and Disease.

Authors:  Carla I Tasca; Débora Lanznaster; Karen A Oliveira; Victor Fernández-Dueñas; Francisco Ciruela
Journal:  Front Cell Neurosci       Date:  2018-10-23       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.